Nov. 4, 2025 — Amplitude Vascular Systems (AVS), a medical device company focused on treating calcified arterial disease, presented the results of the first 95 patients treated in the POWER PAD II U.S ...
VIVA
This channel contains news about the annual Vascular Interventional Advances (VIVA) conference. VIVA is a premier conference for new techniques and technologies to treat vascular disease. This includes the areas of peripheral artery disease (PAD), critical limb ischemia (CLI), endovascular repair and venous therapies.
-
-
Nov. 3, 2025 — Penumbra, Inc. has announced additional results of the STORM-PE randomized controlled trial (RCT), which found that the use of computer assisted vacuum thrombectomy (CAVT) with ...
-
Nov. 4, 2025 – Johnson & Johnson MedTech has announced the one-year results in patients treated with its Shockwave Javelin Peripheral IVL Catheter, a novel Forward IVL platform designed to modify ...
-
Oct. 27, 2025 – Penumbra, Inc. has announced the results of the STORM-PE randomized controlled trial (RCT), which found that the use of mechanical thrombectomy, specifically computer assisted vacuum ...
Nov. 4, 2025 — Amplitude Vascular Systems (AVS), a medical device company focused on treating calcified arterial disease ...
November 09, 2025
Nov. 3, 2025 — Penumbra, Inc. has announced additional results of the STORM-PE randomized controlled trial (RCT), which ...
November 07, 2025
Nov. 4, 2025 – Johnson & Johnson MedTech has announced the one-year results in patients treated with its Shockwave ...
November 06, 2025
Oct. 27, 2025 – Penumbra, Inc. has announced the results of the STORM-PE randomized controlled trial (RCT), which found ...
October 27, 2025
Sept. 9, 2025 — Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating ...
September 12, 2025
November 9, 2023 — The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular ...
November 09, 2023
November 2, 2023 — The latest STRIKE-PE data, presented by Penumbra, Inc. at the Vascular Interventional Advances ...
November 02, 2023
November 2, 2023 — Contego Medical Inc. announced the presentation of late-breaking clinical results from the ...
November 02, 2023
November 2, 2023 — The second round of late-breaking clinical trials results from the Vascular InterVentional Advances ...
November 01, 2023
November 1, 2023 — The VIVA Foundation has announced the results for the first Late-Breaking Clinical Trial sessions at ...
November 01, 2023
October 31, 2023 — Results of four late-breaking clinical trials presented during the The VEINS Conference 2023, taking ...
October 31, 2023
November 3, 2022 — Medtronic, a global leader in medical technology, today announced the results of two clinical studies ...
November 03, 2022
November 2, 2022 — The second round of late-breaking clinical trial results were announced at VIVA22 on Nov. 1 in Las ...
November 02, 2022
November 2, 2022 — A number of awards of distinction were presented during The VEINS (Venous Endovascular INterventional ...
November 02, 2022
October 31, 2022 — Results from the Late-Breaking Clinical Trials session at The VEINS Conference in Las Vegas, NV, were ...
October 31, 2022